NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells

Nidogen-1 (NID1) has been identified as a novel candidate diagnostic biomarker of ovarian cancer in our previous study. Nevertheless, the role of NID1 in the pathogenesis of ovarian cancer is unclear. In the present study, we demonstrated that NID1 was a mesenchymal associated gene and its high expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ya, Zhu, Yuanyuan, Fan, Xiaoyan, Zhang, Chundong, Wang, Yitao, Zhang, Lian, Zhang, Huan, Wen, Tao, Zhang, Kaina, Huo, Xiao, Jiang, Xue, Bu, Youquan, Zhang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464854/
https://www.ncbi.nlm.nih.gov/pubmed/28416770
http://dx.doi.org/10.18632/oncotarget.16145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464854/
https://www.ncbi.nlm.nih.gov/pubmed/28416770
http://dx.doi.org/10.18632/oncotarget.16145

Ejemplares similares